Apixaget (2.5Mg) 30 Tablets
Apixaban anticoagulant tablets for preventing stroke in AFib and treating blood clots.
Apixaget contains Apixaban, a direct oral anticoagulant (DOAC) that selectively inhibits Factor Xa, preventing thrombin generation and blood clot formation. It provides predictable anticoagulation without the need for routine coagulation monitoring. Apixaban offers a favorable safety profile with lower bleeding risk compared to warfarin while maintaining efficacy in stroke prevention and venous thromboembolism treatment.
Purpose
Stroke and systemic embolism prevention in nonvalvular atrial fibrillation, DVT and PE prevention after orthopedic surgery, treatment and secondary prevention of venous thromboembolism.
Ingredients
Apixaban 2.5mg
Warnings
BOXED WARNING: Increased bleeding risk including fatal hemorrhage. Spinal/epidural hematoma risk with neuraxial anesthesia. Premature discontinuation increases thrombosis risk. Not for mechanical heart valves or severe liver disease. Dose adjust for renal impairment. Drug interactions with CYP3A4 and P-gp inducers/inhibitors. Prescription-only.
Side Effects
Bleeding events (major concern): unusual bruising, prolonged bleeding, nosebleeds, gum bleeding, heavy periods, hematuria, melena. Other: headache, nausea, anemia, hypotension.
Storage Instructions
Store at controlled room temperature 15-30°C. Protect from moisture and light. Keep in original packaging. Store out of reach of children.
| Brand | Getz |
| Status | Active |
Related Products
